Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | ioxaglic acid | 3742 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | ioxaglic acid | 3742 | drug-path |
| Asthma | R-HSA-444620 | map05310 | ioxaglic acid | 3742 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | ioxaglic acid | 3742 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | ioxaglic acid | 3742 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | ioxaglic acid | 3742 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | rolitetracycline | 5501 | drug-path |
| Shigellosis | 0 | map05131 | rolitetracycline | 5501 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | rolitetracycline | 5501 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | rolitetracycline | 5501 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | rolitetracycline | 5501 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | rolitetracycline | 5501 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | tridihexethyl | 7699 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | tridihexethyl | 7699 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | tridihexethyl | 7699 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | tridihexethyl | 7699 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | tridihexethyl | 7699 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tridihexethyl | 7699 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | tridihexethyl | 7699 | drug-path |
| Shigellosis | 0 | map05131 | tridihexethyl | 7699 | drug-path |